Michael Gelband ExodusPoint Capital Management
Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VMW
VMware, Inc
VMW
|
+$90M |
| 2 |
ExxonMobil
XOM
|
+$88.4M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$87.3M |
| 4 |
NiSource
NI
|
+$81.2M |
| 5 |
CMS Energy
CMS
|
+$70.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Global Payments
GPN
|
+$356M |
| 2 |
Duke Energy
DUK
|
+$72.3M |
| 3 |
Pinnacle West Capital
PNW
|
+$61M |
| 4 |
Occidental Petroleum
OXY
|
+$59.8M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$58.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 11.65% |
| 2 | Technology | 10.24% |
| 3 | Utilities | 9.2% |
| 4 | Industrials | 8.85% |
| 5 | Energy | 8.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MOR
726
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $1.72M | 0.02% |
+255,564
| New | +$1.97M |
|
727
Rollins
ROL
$17.9B
| $1.7M | 0.02% |
+45,555
| New | +$1.84M |
|
728
Arcosa
ACA
$7.13B
| $1.69M | 0.02% |
23,512
-33,291
| -59% | -$2.53M |
|
729
Fulton Financial
FULT
$4.5B
| $1.69M | 0.02% |
139,532
+86,587
| +164% | +$1.14M |
|
730
Central Garden & Pet Co Class A
CENTA
$2.4B
| $1.68M | 0.02% |
+52,464
| New | +$1.67M |
|
|
HOLX
731
DELISTED
Hologic
HOLX
| $1.68M | 0.02% |
24,209
-59,098
| -71% | -$4.47M |
|
732
Liberty Media Series C
FWONK
$26.7B
| $1.67M | 0.02% |
26,852
+7,843
| +41% | +$538K |
|
733
Jefferies Financial Group
JEF
$12B
| $1.67M | 0.02% |
+45,682
| New | +$1.64M |
|
734
TransUnion
TRU
$16.3B
| $1.67M | 0.02% |
+23,307
| New | +$1.83M |
|
|
THS
735
DELISTED
Treehouse Foods
THS
| $1.67M | 0.02% |
+38,284
| New | +$1.83M |
|
736
Savers
SVV
$1.67B
| $1.67M | 0.02% |
89,275
+26,875
| +43% | +$620K |
|
737
Ligand Pharmaceuticals
LGND
$5.59B
| $1.67M | 0.02% |
27,783
+6,473
| +30% | +$426K |
|
738
PJT Partners
PJT
$4.51B
| $1.66M | 0.02% |
+20,944
| New | +$1.62M |
|
739
Cullen/Frost Bankers
CFR
$10.2B
| $1.66M | 0.02% |
18,208
+10,373
| +132% | +$1.05M |
|
740
Healthcare Services Group
HCSG
$1.56B
| $1.66M | 0.02% |
158,747
-25,458
| -14% | -$317K |
|
741
Ironwood Pharmaceuticals
IRWD
$682M
| $1.66M | 0.02% |
171,950
+125,721
| +272% | +$1.23M |
|
|
AUTL
742
Autolus Therapeutics
AUTL
$623M
| $1.66M | 0.02% |
710,355
-67,405
| -9% | -$192K |
|
|
SNV
743
DELISTED
Synovus
SNV
| $1.66M | 0.02% |
59,535
-43,616
| -42% | -$1.36M |
|
744
KE Holdings
BEKE
$19.5B
| $1.65M | 0.02% |
+106,446
| New | +$1.69M |
|
745
On Holding
ONON
$9.86B
| $1.65M | 0.02% |
59,328
+51,067
| +618% | +$1.62M |
|
|
BDN
746
Brandywine Realty Trust
BDN
$548M
| $1.65M | 0.02% |
363,294
+138,667
| +62% | +$660K |
|
747
Dyne Therapeutics
DYN
$4.85B
| $1.65M | 0.02% |
184,010
+149,526
| +434% | +$1.61M |
|
748
Bankunited
BKU
$3.3B
| $1.65M | 0.02% |
72,576
+60,420
| +497% | +$1.55M |
|
749
TG Therapeutics
TGTX
$8.57B
| $1.63M | 0.02% |
195,167
+39,519
| +25% | +$551K |
|
750
Acadia Realty Trust
AKR
$2.93B
| $1.63M | 0.02% |
113,280
-46,257
| -29% | -$700K |
|
Similar funds
Michael Gelband's Q3 2023 Portfolio in Review
As of Q3 2023, Michael Gelband held 2,289 positions worth $10.5B, down 15% from $12.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Michael Gelband withdrew a net $1.43B in Q3 2023, closing 654 positions and reducing 594 holdings. Its most notable exit was Pinnacle West Capital, an estimated $61M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 9.1% a quarter earlier, followed by Technology and Utilities.
Against the trend, Michael Gelband opened a new position in ExxonMobil worth $94.8M.
- Michael Gelband's largest Q3 2023 buy was ExxonMobil: 806,107 shares worth $94.8M.
- Michael Gelband added most to VMware, Inc in Q3 2023, an estimated $90M increase.
- Michael Gelband's biggest Q3 2023 reduction was Global Payments, cutting an estimated $356M.
- Michael Gelband fully exited Pinnacle West Capital in Q3 2023, selling an estimated $61M.
- Michael Gelband's ten largest holdings make up 23% of its $10.5B portfolio in Q3 2023.
- Michael Gelband opened 494 new positions and closed 654 in Q3 2023.
- Michael Gelband's portfolio value fell 15% quarter-over-quarter to $10.5B.
Based on ExodusPoint Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.